Abstract:The revolutionary CRISPR/Cas9 gene editing technology holds immense potential for treating genetic diseases and tackling conditions like cancer. However, efficient delivery remains a significant challenge. This is where nanoparticles come into play, emerging as powerful allies in the realm of drug delivery. Nanoparticles can accommodate larger insertion sizes, enabling the incorporation of larger Cas9 enzymes and complex guide RNAs, thus opening up the possibility of editing previously inaccessible genetic regions. Their relatively straightforward and scalable production processes make them cost-effective options for wider applications. Notably, nanoparticles excel in vivo, demonstrating efficient tissue penetration and targeted delivery, which are crucial for maximizing therapeutic impact while minimizing side effects. This review aims to explore the potential of nanoparticle-based delivery systems for CRISPR/Cas9, highlighting their advantages and challenges in gene editing applications. The diverse range of nanoparticles further bolsters their potential. Polymeric nanoparticles, for instance, offer tunable properties for customization and controlled release of the CRISPR cargo. Lipid-based nanoparticles facilitate efficient cellular uptake and endosomal escape, ensuring the CRISPR components reach the target DNA. Even gold nanoparticles, known for their unique biocompatibility and photothermal properties, hold promise in light-activated editing strategies. Non-viral delivery systems, particularly those based on nanoparticles, stand out due to their inherent advantages. Collectively, the evidence paints a promising picture: nanoparticles are not merely passive carriers but active participants in the CRISPR/Cas9 delivery landscape. Their versatility, efficiency, and safety position them as key enablers of a future where gene editing can revolutionize drug development, offering personalized and targeted therapies for a wide range of diseases.

Nanobiomaterial Vectors for Improving Gene Editing and Gene Therapy

Nano-vectors for CRISPR/Cas9-mediated genome editing

[Nanobiotechnological Gene Transfer Vectors in Gene Therapy].

Viral and nonviral nanocarriers for in vivo CRISPR-based gene editing

Intelligent nanotherapeutic strategies for the delivery of CRISPR system

Nanotechnology Based CRISPR/Cas9 System Delivery for Genome Editing: Progress and Prospect

Nanoparticles in Gene Therapy: Principles, Prospects, and Challenges

Non-viral Nanocarriers for CRISPR-Cas9 Gene Editing System Delivery

Strategies for nonviral nanoparticle-based delivery of CRISPR/Cas9 therapeutics

Engineered materials for in vivo delivery of genome-editing machinery

Nanoparticle Delivery of CRISPR/Cas9 for Genome Editing

Cationic Polymeric Nanoformulation: Recent Advances in Material Design for CRISPR/Cas9 Gene Therapy

Engineered Nanomaterials to Potentiate CRISPR/Cas9 Gene Editing for Cancer Therapy

Nanoparticle Carriers: A New Era of Precise CRISPR/Cas9 Gene Editing.

Key Considerations in Designing CRISPR/Cas9-carrying Nanoparticles for Therapeutic Genome Editing.

Key Considerations In Designing Crispr/Cas9-Carrying Nanoparticles For Therapeutic Genome Editing

Biomaterial-assisted targeted and controlled delivery of CRISPR/Cas9 for precise gene editing

Dibenzocyclooctyne-Branched Primer Assembled Gene Nanovector and Its Potential Applications in Genome Editing.

Viral and Non-Viral Systems to Deliver Gene Therapeutics to Clinical Targets

Gold Nanoparticle-Mediated Gene Therapy

When Mrna Meets Gene Editing